Shareholder rights plan

Citi Trends Adopts Limited Duration Stockholder Rights Plan

Retrieved on: 
Wednesday, December 6, 2023

The Rights Plan is also intended to provide the Board sufficient time to make informed judgments and take actions that are in the best interests of Citi Trends and all of its stockholders.

Key Points: 
  • The Rights Plan is also intended to provide the Board sufficient time to make informed judgments and take actions that are in the best interests of Citi Trends and all of its stockholders.
  • The Rights Plan is similar to stockholder rights plans adopted by other publicly held companies.
  • However, any owner of the relevant triggering percentage or more may not, subject to the terms of the Rights Plan, acquire any additional shares without triggering the Rights Plan.
  • The Board intends to submit the Rights Plan to stockholders for ratification at the Company’s upcoming Annual Meeting of Stockholders (the “Annual Meeting”) and to terminate the Rights Plan if the proposal to ratify the Rights Plan is not approved at that meeting.

Li-Cycle Adopts Limited Duration Shareholder Rights Plan

Retrieved on: 
Wednesday, November 1, 2023

Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan (the “Rights Plan”).

Key Points: 
  • Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan (the “Rights Plan”).
  • The Rights Plan also helps ensure that the Board has sufficient time to make informed, deliberate decisions and take actions that are in the best interests of Li-Cycle.
  • The Rights Plan applies equally to all current and future shareholders of Li-Cycle.
  • The Rights Plan will operate similarly to rights plans adopted by other companies publicly listed in the United States.

Tempest Adopts Limited Duration Stockholder Rights Plan

Retrieved on: 
Wednesday, October 11, 2023

BRISBANE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan, effective immediately (the “Rights Plan”).

Key Points: 
  • BRISBANE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan, effective immediately (the “Rights Plan”).
  • We intend the Rights Plan to enable all of our stockholders to realize the long-term value of their investment.
  • The Rights Plan will expire on October 10, 2024 or, if Tempest’s stockholders approve the Rights Plan, on October 10, 2026, unless the rights are earlier redeemed by the Company.
  • Additional information regarding the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.

Staffing 360 Solutions, Inc. Adopts Limited Duration Stockholder Rights Plan

Retrieved on: 
Monday, October 2, 2023

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (Nasdaq: STAF) (“Staffing 360 Solutions” or the “Company”), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan (the “Rights Plan”).

Key Points: 
  • NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (Nasdaq: STAF) (“Staffing 360 Solutions” or the “Company”), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan (the “Rights Plan”).
  • The adoption of the Rights Plan is intended to protect the long-term interests of the Company and all of the Company’s stockholders and enable them to realize the full potential value of their investment in the Company.
  • The Rights Plan is not intended to prevent or interfere with any action with respect to the Company that the Board determines to be in the best interests of the Company and its stockholders.
  • The Rights Plan will encourage anyone seeking to gain a significant interest in the Company to negotiate directly with the Board prior to attempting to control or significantly influence the Company.

Blackbaud Extends Existing Stockholder Rights Plan

Retrieved on: 
Monday, October 2, 2023

CHARLESTON, S.C., Oct. 2, 2023 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact ("Blackbaud" or the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to the company's existing stockholder rights plan (the "Rights Plan"), pursuant to which the expiration date has been extended from October 2, 2023 to October 2, 2024.

Key Points: 
  • CHARLESTON, S.C., Oct. 2, 2023 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact ("Blackbaud" or the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to the company's existing stockholder rights plan (the "Rights Plan"), pursuant to which the expiration date has been extended from October 2, 2023 to October 2, 2024.
  • All other terms and conditions of the Rights Plan previously adopted in October 2022 remain unchanged.
  • The Company expects to submit the amendment to the Rights Plan to the Company's stockholders for ratification at the Company's upcoming 2024 annual meeting of stockholders.
  • The Board approved the one-year extension of the Rights Plan to protect the interests of all Company stockholders.

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Retrieved on: 
Monday, October 2, 2023

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration stockholder rights plan (“Rights Plan”) under which stockholders will receive rights to purchase a new series of preferred stock in certain circumstances.

Key Points: 
  • MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration stockholder rights plan (“Rights Plan”) under which stockholders will receive rights to purchase a new series of preferred stock in certain circumstances.
  • We believe it is imperative that MEI stockholders are given the opportunity to realize the full long-term potential of their MEI investment.
  • Pursuant to the Rights Plan, the Company is issuing one right for each share of common stock as of the close of business on October 12, 2023.
  • Further details about the Rights Plan will be contained in a Form 8-K to be filed by the Company with the Securities and Exchange Commission.

Stratasys to Explore Strategic Alternatives to Maximize Shareholder Value

Retrieved on: 
Thursday, September 28, 2023

Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”), a leader in polymer 3D printing solutions, today announced that its Board of Directors has initiated a process to explore strategic alternatives for the Company.

Key Points: 
  • Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”), a leader in polymer 3D printing solutions, today announced that its Board of Directors has initiated a process to explore strategic alternatives for the Company.
  • Potential strategic alternatives to be explored or evaluated may include, but are not limited to, a strategic transaction, potential merger, business combination or sale.
  • “We have decided to undertake a comprehensive and thorough review of all available strategic alternatives,” said Dov Ofer, Chairman of Stratasys’ Board of Directors.
  • Importantly, we remain focused on our mission to deliver value to customers and are committed to taking the appropriate actions to maximize value for all Stratasys shareholders.”
    There can be no assurance that the Company’s strategic review process will result in any transaction or other strategic outcome.

Cue Health Adopts Limited-Duration Shareholder Rights Plan

Retrieved on: 
Thursday, September 21, 2023

Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the “Rights Plan”) to protect the long-term interests of all shareholders.

Key Points: 
  • Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the “Rights Plan”) to protect the long-term interests of all shareholders.
  • The Board adopted the Rights Plan in response to a rapid accumulation of shares by a third party.
  • The Rights Plan is effective immediately and has a one-year term, expiring on September 20, 2024.
  • The Rights Plan does not preclude the Board from considering an offer that recognizes the full value of Cue.

Nasdaq Study Shows Legacy Technology and Regulation Preventing Financial Institutions From Capturing Growth Opportunities

Retrieved on: 
Thursday, September 14, 2023

NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today published the results of a major global survey across the post-trade ecosystem, including over 300 decision makers from exchange groups, custodians, brokers, and other service providers. The report was produced in partnership with the ValueExchange.

Key Points: 
  • The landmark study reveals that 78% of Financial Market Infrastructure (FMI) investment budgets are dominated by maintaining and upgrading legacy technology platforms.
  • This is leaving very little scope for spending on growth initiatives and highlights an ever-increasing risk for the industry.
  • Roland Chai, Executive Vice President and Head of Marketplace Technology at Nasdaq, said: “Over decades technology debt has built up amongst infrastructure providers across financial markets.
  • The study finds the reach of mandatory regulatory change is the central concern for 64% of our respondents.

LifeVantage Adopts Limited Duration Stockholder Rights Plan

Retrieved on: 
Thursday, August 31, 2023

SALT LAKE CITY, Aug. 31, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan (the “Rights Plan”).

Key Points: 
  • SALT LAKE CITY, Aug. 31, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced that its Board of Directors (the “Board”) has adopted a limited duration stockholder rights plan (the “Rights Plan”).
  • The adoption of the Rights Plan is intended to protect the long-term interests of LifeVantage and all LifeVantage stockholders and enable them to realize the full potential value of their investment in the Company.
  • The Board intends to submit the Rights Plan to stockholders for ratification at the Company’s upcoming Annual Meeting of Stockholders (the “Annual Meeting”) and to terminate the Rights Plan if the proposal to ratify the Rights Plan is not approved at that meeting.
  • If the Rights Plan is ratified at the Annual Meeting, it will expire no later than August 28, 2024, subject to the terms of the Rights Plan.